• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wall Street's Most Accurate Analysts Weigh In On 3 Risk Off Stocks Delivering High-Dividend Yields

    7/24/24 8:16:18 AM ET
    $K
    $MO
    $PM
    Packaged Foods
    Consumer Staples
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $K alert in real time by email

    During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

    Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.

    Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.

    Kellanova (NYSE:K)

    • Dividend Yield: 3.96%
    • B of A Securities analyst Bryan Spillane maintained a Neutral rating and cut the price target from $64 to $62 on July 10. This analyst has an accuracy rate of 69%.
    • JP Morgan analyst Ken Goldman maintained a Neutral rating and raised the price target from $59 to $66 on May 3. This analyst has an accuracy rate of 80%.
    • Recent News: Kellanova will issue its second quarter financial results on Thursday, Aug. 1.
    • Benzinga Pro's real-time newsfeed alerted to latest Kellanova news

    Philip Morris International Inc. (NYSE:PM)

    • Dividend Yield: 4.75%
    • Stifel analyst Matthew Smith maintained a Buy rating and raised the price target from $108 to $115 on April 24. This analyst has an accuracy rate of 60%.
    • Argus Research analyst David Colemandowngraded the stock from Buy to Hold on March 5. This analyst has an accuracy rate of 63%.
    • Recent News: On July 23, Philip Morris International reported better-than-expected second-quarter financial results and raised its FY24 adjusted EPS guidance.
    • Benzinga Pro's charting tool helped identify the trend in PM's stock.

    Altria Group, Inc. (NYSE:MO)

    • Dividend Yield: 7.98%
    • Stifel analyst Matthew Smithreiterated a Buy rating with a price target of $50 on March 25. This analyst has an accuracy rate of 60%.
    • Morgan Stanley analyst Pamela Kaufman reiterated an Equal-Weight rating with a price target of $45 on July 18, 2023. This analyst has an accuracy rate of 69%.
    • Recent News: Altria Group will report its second-quarter and first-half business results on July 31.
    • Benzinga Pro's signals feature notified of a potential breakout in MO shares.

    Read More:

    • Best Buy, Kroger And 2 Other Stocks Insiders Are Selling
    Get the next $K alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $K
    $MO
    $PM

    CompanyDatePrice TargetRatingAnalyst
    Philip Morris International Inc
    $PM
    1/20/2026$180.00Buy → Hold
    Jefferies
    Altria Group Inc.
    $MO
    1/9/2026$63.00Neutral → Buy
    UBS
    Kellanova
    $K
    8/20/2025$83.50Neutral
    Analyst
    Philip Morris International Inc
    $PM
    7/9/2025$220.00Buy
    Jefferies
    Altria Group Inc.
    $MO
    7/9/2025$50.00Underperform
    Jefferies
    Altria Group Inc.
    $MO
    7/2/2025$59.00Sell → Neutral
    UBS
    Kellanova
    $K
    5/29/2025$83.50Neutral
    Citigroup
    Philip Morris International Inc
    $PM
    5/22/2025$195.00Buy
    Needham
    More analyst ratings

    $K
    $MO
    $PM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Group Controller Dobrowolski Reginaldo covered exercise/tax liability with 22 shares (SEC Form 4)

    4 - Philip Morris International Inc. (0001413329) (Issuer)

    3/9/26 4:23:03 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    SVP, Chief HR Off. & CCO Whitaker Charles N. sold $1,885,718 worth of shares (27,908 units at $67.57), decreasing direct ownership by 13% to 180,869 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    3/9/26 2:38:41 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    EVP & General Counsel Mccarter Robert A. Iii was granted 5,767 shares and covered exercise/tax liability with 4,517 shares, increasing direct ownership by 1% to 123,612 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    3/2/26 3:47:47 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $K
    $MO
    $PM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    on! PLUS™ Expands Nationwide Retail Availability

    Altria Group, Inc. (Altria) (NYSE:MO) today announced the national retail expansion of on! PLUS™ nicotine pouches, a next-generation oral nicotine pouch product manufactured by Helix Innovations LLC (Helix), an Altria operating company. "The national expansion of on! PLUS is an exciting milestone for Helix and a meaningful step forward in Altria's Vision of Moving Beyond Smoking®. As adult consumers continue to seek smoke‑free alternatives, on! PLUS reflects our focus on quality, innovation, and responsibly meeting demand within science‑based regulatory frameworks," said Nick MacPhee, Managing Director, Helix. on! PLUS is the first product authorized through the U.S. Food and Drug Admin

    3/23/26 3:30:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

    Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.47 per common share, payable on April 13, 2026, to shareholders of record as of March 19, 2026. The ex-dividend date is March 19, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily

    3/5/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    PMI U.S. Invests in Communities; Announces $150,000 Grant to Support California Asian Pacific Chamber of Commerce

    Grant Opens Doors for Entrepreneurs and Expands Economic Opportunity Across the Golden State STAMFORD, Conn., March 4, 2026 /PRNewswire/ -- Today, Philip Morris International's U.S. businesses ("PMI U.S.")  announced a $150,000 donation to the California Asian Pacific Chamber of Commerce (CalAsian Chamber) further demonstrating PMI U.S.'s commitment to investing in communities. The contribution will support the Chamber's Main Street Small Business Impact Program and Small Business Utilization Center. These programs provide hands-on technical assistance that has helped California

    3/4/26 9:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $K
    $MO
    $PM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Philip Morris International downgraded by Jefferies with a new price target

    Jefferies downgraded Philip Morris International from Buy to Hold and set a new price target of $180.00

    1/20/26 9:10:49 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria upgraded by UBS with a new price target

    UBS upgraded Altria from Neutral to Buy and set a new price target of $63.00

    1/9/26 8:23:08 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Analyst resumed coverage on Kellanova with a new price target

    Analyst resumed coverage of Kellanova with a rating of Neutral and set a new price target of $83.50

    8/20/25 8:56:44 AM ET
    $K
    Packaged Foods
    Consumer Staples

    $K
    $MO
    $PM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Davis Robert Matthews bought $48,599 worth of shares (1,200 units at $40.50), increasing direct ownership by 16% to 8,473 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:08:44 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Clarke Ian L.T. bought $44,625 worth of shares (1,100 units at $40.57), increasing direct ownership by 18% to 7,145 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:03:21 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $K
    $MO
    $PM
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Philip Morris International Inc

    SCHEDULE 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    3/27/26 11:22:44 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Altria Group Inc.

    SCHEDULE 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)

    3/26/26 3:26:17 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEFA14A filed by Philip Morris International Inc

    DEFA14A - Philip Morris International Inc. (0001413329) (Filer)

    3/26/26 6:06:32 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $K
    $MO
    $PM
    Financials

    Live finance-specific insights

    View All

    Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

    Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.47 per common share, payable on April 13, 2026, to shareholders of record as of March 19, 2026. The ex-dividend date is March 19, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily

    3/5/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Declares Regular Quarterly Dividend of $1.06 Per Share

    Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.06 per share, payable on April 30, 2026 to shareholders of record as of March 25, 2026. The ex-dividend date is March 25, 2026. View source version on businesswire.com: https://www.businesswire.com/news/home/20260225648687/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 www.altria.com/contact-us/media

    2/26/26 1:00:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Presents at 2026 CAGNY Conference; Reaffirms 2026 Full-Year Forecast

    Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE:PM) Group CEO PMI, Jacek Olczak, and Group Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2026 Consumer Analyst Group of New York (CAGNY) Conference at approximately 10:00 a.m. ET. The live webcast and presentation slides will be available here. The webcast replay will be available at the same link for six months after the event. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at www.pmi.com/irapp. The presentation will cover: How a transformed PMI is leading the industry in an evolving operating environment; The success and future opportu

    2/18/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $K
    $MO
    $PM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Kellanova

    SC 13D - KELLANOVA (0000055067) (Subject)

    8/20/24 4:15:56 PM ET
    $K
    Packaged Foods
    Consumer Staples

    SEC Form SC 13D filed by Kellanova

    SC 13D - KELLANOVA (0000055067) (Subject)

    8/19/24 5:17:35 PM ET
    $K
    Packaged Foods
    Consumer Staples

    SEC Form SC 13G/A filed by Altria Group Inc. (Amendment)

    SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)

    2/13/24 4:58:48 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $K
    $MO
    $PM
    Leadership Updates

    Live Leadership Updates

    View All

    Philip Morris International Opens Dialogue on the Future of Human Cognition as a Defining Frontier in the Age of AI

    The paper calls for global debate to ensure AI enhances—rather than diminishes—uniquely human strengths in an increasingly automated world Philip Morris International Inc. (NYSE:PM) today released a new white paper, "Human Cognition: The Next Frontier?", inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy. The white paper explores how human capabilities such as - critical thinking, creativity and adaptability - are poised to become the "superskill" of the future, driving progress in an era of human-machine collaboration. As AI automates routine ta

    1/20/26 5:03:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group, Inc. Announces Retirement of CEO Billy Gifford and Appointment of Sal Mancuso as Successor

    Altria Group, Inc. (Altria) (NYSE:MO) announces today that Billy Gifford, Altria's Chief Executive Officer (CEO), has decided to retire, effective May 14, 2026 at the conclusion of the 2026 Annual Meeting of Shareholders (2026 Annual Meeting). Billy has had a distinguished career of over 30 years with the Altria family of companies and has served as Altria's CEO since 2020. Altria's Board of Directors (Board) has elected Salvatore (Sal) Mancuso to serve as Altria's CEO upon Billy's retirement. To facilitate a smooth transition, Billy plans to serve as a consultant to Altria upon his retirement through at least the end of 2026. Additionally, the Board elected Heather Newman to serve as Altri

    12/11/25 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Ares Management Set to Join S&P 500; Sezzle and Vital Farms to Join S&P SmallCap 600

    NEW YORK, Dec. 8, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500 and S&P SmallCap 600:  Ares Management (NYSE:ARES) will replace Kellanova (NYSE:K) in the S&P 500 effective prior to the open of trading on Thursday, December 11. Mars Inc. is acquiring Kellanova in a deal expected to close soon, pending final closing conditions.Vital Farms Inc. (NASD: VITL) will replace Heidrick & Struggles Intl Inc. (NASD: HSII) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, December 11. Advent International and Corvex Private Equity are acquiring Heidrick & Struggles Intl in a deal expected to be completed soon, pending final closing

    12/8/25 5:57:00 PM ET
    $ARES
    $CRGY
    $HSII
    Investment Managers
    Finance
    Oil & Gas Production
    Energy